Polaroid Therapeutics
Markus Rothmaier is an experienced professional in research and development, currently serving as Head of Research and Development at Polaroid Therapeutics since April 2024, focusing on antimicrobial technology for medical devices. Prior to this role, Markus held the position of Head of R&D at IVF HARTMANN AG from May 2009 to March 2024, where contributions included the development of superabsorbent and antimicrobial wound dressings and various medical products in compliance with ISO 13485 and FDA regulations. Additional experience includes project management roles encompassing dermal drug delivery systems at IVF HARTMANN AG and applied R&D projects in cancer therapy and biomedical devices at Empa. Markus has also served as Head of R&D at SENSORIX AG, worked as a research associate at ETH Zurich and the University of Alberta, and holds advanced degrees in Medical Physics, Analytical Chemistry, and Chemistry from ETH Zürich.
This person is not in any teams
Polaroid Therapeutics
Polaroid Therapeutics, founded in 2022, is a healthcare company focused on developing innovative antimicrobial solutions for wound healing and additional indications with unmet medical needs. As a spinoff of Polaroid Sciences, our mission is to bring to life the best of Polaroid's vision of creating a more human and meaningful world through cutting-edge technology and research. Our proprietary technology is designed to address major challenges in antimicrobial therapies and improve patient outcomes. We are committed to positively impacting the lives of patients and their families by delivering superior treatments that prevent, heal, and improve the quality of life. We aspire to reach and help all humankind around the globe.